Pfizer’s latest trial results for their mRNA flu vaccine reveal a shocking truth: the shot appears to do more harm than good, especially for our elderly population. The company went into this trial full of optimism, but what they discovered was so damning that they buried the data, revealing a troubling trend in how large pharmaceutical companies handle their messaging and accountability. Instead of transparency, Pfizer opted for a cover-up, keeping critical information hidden from the public eye.
The facts are incredibly concerning. Pfizer’s mRNA flu vaccine was associated with a staggering six times more adverse events compared to the infections it prevented in adults under 65. It gets even worse for the elderly, where the vaccine was linked to more deaths and severe injuries than the traditional flu shot. This is a betrayal of trust from a company that has pushed vaccines under the guise of public safety. How can they expect the American people to believe their claims when their own trials suggest that their products could be putting lives at risk?
The delays and the selective reporting surrounding these trial results are alarming. By hiding their unfavorable findings in a hidden corner of the government’s clinical trials website, they demonstrate a disturbing lack of commitment to accountability. Instead of owning up to the shortcomings of their vaccine, Pfizer chose to highlight the more favorable results while completely glossing over the devastating outcomes for those over 65. This is not just bad business; it’s a blatant disregard for the health and safety of vulnerable populations.
Additionally, the effectiveness rates touted by Pfizer are hardly impressive. With an absolute difference of 0.32% for those under 65, it’s evident that the mRNA vaccine does not provide substantial benefits. For every mild flu-like illness it prevents, it causes a significant number of severe reactions. This raises serious questions about the ethics and safety of mRNA vaccines. The American public deserves to know the whole truth, not just the cherry-picked data that makes Pfizer look good.
This is not just a Pfizer problem; it reflects a larger issue within our healthcare system. The FDA’s role in approving these vaccines must be critically scrutinized. The agency should prioritize randomized trials and real clinical outcomes, not just the data that Big Pharma hands them. This reckless approach contributed to the erosion of public trust in vaccines, which is further exacerbated by the reluctance of these organizations to admit mistakes or failures.
Americans deserve better than the obfuscation and incompetence we have witnessed. We demand transparency. We demand accountability. Our health is not a game, and the stakes are too high for pharmaceutical companies to play fast and loose with safety data. Scandals like these only serve to fuel skepticism and distrust against an industry that should be acting in the best interests of the public. Will we continue to allow powerful corporations to dictate our health without scrutiny, or will we fight for the truth and the safety of our families?
Source: Just The News
Leave a Reply